Battle of the Wellness Giants: Hexagon Nutrition, Nestlé India, and Zydus Wellness Compete for Market Supremacy

Hexagon Nutrition is set to enter the public markets with its IPO scheduled from June 5 to June 9, 2026. The issue price is expected to range between INR 42 to 45 per share, with a total IPO size of approximately INR 129.61 to 138.87 crore through the Offer for Sale (OFS) of 3,08,59,704 shares. The minimum bid is set at 333 shares, requiring an investment of around INR 14,985. This IPO will be closely watched by investors in the Indian stock market, particularly those interested in the nutrition and wellness sector, which remains largely dominated by established FMCG giants like Nestlé and Zydus Wellness.

In terms of grey market sentiment, initial indicators suggest a cautious approach from investors. While Hexagon Nutrition’s valuation appears attractive at a P/E ratio of approximately 24 to 25x—substantially lower than Nestlé’s nearly 78x and Zydus’s 69x—investors are wary due to the operational risks highlighted in recent assessments. These include significant quality control failures and challenges in maintaining repeat business, indicating that recent financial improvements may not suffice to assure market confidence fully.

For Indian investors, the Hexagon Nutrition IPO represents a mixed opportunity. On one hand, its lower valuation multiples may appear appealing, especially in comparison to more established peers. However, the serious operational issues, lack of fresh capital influx due to the 100% OFS structure, and regulatory challenges at key facilities raise red flags. Thus, while Hexagon may exhibit growth potential, investors are advised to proceed with caution and perform thorough due diligence before making investment decisions in this IPO.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)